https://www.selleckchem.com/products/indy.html
We present a novel stentless filtration system used to create a permanent sclerocorneal drainage channel that reduces intraocular pressure (IOP) without the need to create a conjunctival incision or a scleral flap. The purpose of this study was to evaluate the safety, feasibility, and preliminary performance of a novel surgical system, the minimally invasive micro sclerostomy (MIMS), in an in vivo porcine experimental model. MIMS is an ab externo stentless filtration procedure. An activation system is used to operate a handpiece that inclu
Like
Comment
Share
